Prognostic utility of mid-regional pro-adrenomedullin and growth differentiation factor 15 in patients undergoing transfemoral transcatheter aortic valve implantation
Novel circulating biomarkers like MR-proADM and GDF-15 may provide additional value in predicting survival after TAVI.
Authors
- Kerstin Piayda (ORCID: https://orcid.org/0000-0002-9746-7592)
- Christian W. Hamm (ORCID: https://orcid.org/0000-0001-6763-4161)
- Christoph Liebetrau (ORCID: https://orcid.org/0000-0002-5499-7024)
- Won‐Keun Kim (ORCID: https://orcid.org/0000-0002-0799-7478)
- Christian Troidl (ORCID: https://orcid.org/0000-0002-5574-9786)
- Samuel Tobias Sossalla (ORCID: https://orcid.org/0000-0001-8034-2673)
- Mani Arsalan (ORCID: https://orcid.org/0000-0001-5861-891X)
- Pascal Bauer (ORCID: https://orcid.org/0000-0002-6036-8689)
- Holger Nef (ORCID: https://orcid.org/0000-0002-2823-3928)
- Stanislav Keranov (ORCID: https://orcid.org/0000-0002-4379-4424)
- Sandra Voss (ORCID: https://orcid.org/0009-0007-6852-634X)
- Oliver Dörr (ORCID: https://orcid.org/0000-0003-4526-6956)
- Franz Hofmann (ORCID: https://orcid.org/0000-0001-8571-1001)
- Luisa Schulz
Institutions
- Goethe University Frankfurt (DE)
- Justus-Liebig-Universität Gießen (DE)
- Cardiovascular Center Bethanien (DE)
- German Centre for Cardiovascular Research (DE)
- Kerckhoff Klinik (DE)
- Segeberger Kliniken (DE)
Publication Details
- Journal
- Clinical Research in Cardiology
- Published
- 2024-10-25
- DOI
- https://doi.org/10.1007/s00392-024-02560-w
- Citations
- 1
- Primary Topic
- Heart Failure Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.40